SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-028479
Filing Date
2016-11-09
Accepted
2016-11-09 08:00:42
Documents
3
Period of Report
2016-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ATRS-8K-20151105 atrs-8k_20161109.htm 8-K 31125
2 EX-99.1 PRESS RELEASE atrs-ex991_43.htm EX-99.1 330153
3 GRAPHIC g20161108223325570546.jpg GRAPHIC 17898
  Complete submission text file 0001564590-16-028479.txt   387488
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 161982835
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10